# Autologous Bone Marrow Stem Cell Therapy for Autism

> **NCT02627131** · PHASE2 · COMPLETED · sponsor: **Vinmec Healthcare System** · enrollment: 24 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **BIOLOGICAL:** Autologous Bone Marrow Mononuclear Cells

## Key facts

- **NCT ID:** NCT02627131
- **Lead sponsor:** Vinmec Healthcare System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627131, "Autologous Bone Marrow Stem Cell Therapy for Autism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02627131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*